Our findings suggested that decreased SOD activity was associated with increased MS independently of cellular aging and OS markers, as well as the dietary risk factors, which was partially and synergistically mediated by impaired insulin sensitivity and β-cell dysfunction. Here, SOD1 is linked to myeloid sarcoma.